PTSD

Latest News

thumbs down
FDA Advisory Committee Votes Against Recommending Brexpiprazole Plus Sertraline for PTSD

July 18th 2025

The FDA advisory committee votes against brexpiprazole plus sertraline for PTSD, citing insufficient efficacy despite some positive trial results.

question
Rexulti for PTSD: “Discordant Results” Flagged by FDA Reviewers

July 17th 2025

PTSD
Rexulti in Combination With Sertraline for PTSD: Upcoming FDA Advisory Committee Discussion

July 16th 2025

Lone Star Elegy
Lone Star Elegy

July 14th 2025

TSND-201 Receives Breakthrough Therapy Designation From FDA for PTSD
TSND-201 Receives Breakthrough Therapy Designation From FDA for PTSD

July 10th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.